VXN
Vexin
Also known as: C8orf46, MGC33510, VEXIN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TAG6
- Gene
- VXN
- Ensembl
- ENSG00000169085
- Chromosome
- 8
- Canonical length
- 207 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
Predicted to be involved in neuron differentiation. Predicted to be located in nucleus and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
207 residues, UniProt reviewed canonical sequence.
>Q8TAG6|VXN
1 MMHQIYSCSD ENIEVFTTVI PSKVSSPARR RAKSSQHLLT KNVVIESDLY THQPLELLPH
61 RGDRRDPGDR RRFGRLQTAR PPTAHPAKAS ARPVGISEPK TSNLCGNRAY GKSLIPPVPR
121 ISVKTSASAS LEATAMGTEK GAVLMRGSRH LKKMTEEYPA LPQGAEASLP LTGSASCGVP
181 GILRKMWTRH KKKSEYVGAT NSAFEADLocalizationUniProt · AlphaFold · HPA
Whether an antibody against VXN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.73
- Highest tissue expression
- 113 nTPM
Expression across tissuesHPA
Tissue
- hippocampal formation: 113 nTPM
- spinal cord: 87 nTPM
- cerebral cortex: 81 nTPM
- amygdala: 56 nTPM
- midbrain: 56 nTPM
- basal ganglia: 42 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 40 nCPM
- oligodendrocytes: 37 nCPM
- brain excitatory neurons: 25 nCPM
- proximal tubule cells: 15 nCPM
- astrocytes: 14 nCPM
- loop of henle epithelial cells: 13 nCPM
Immune cell
- memory CD8 T-cell: 0.1 nTPM
- myeloid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- hippocampal formation: 223 nTPM
- white matter: 133 nTPM
- cerebral cortex: 129 nTPM
- basal ganglia: 111 nTPM
- midbrain: 79 nTPM
- pons: 79 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.8
- gnomAD pLI
- 0.13
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Vexin domain
- Vexin
- Vexin domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads VXN as an antibody target. Whether an autoantibody or antibody against VXN could matter depends on whether native VXN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
VXN is annotated at the cell surface, where native VXN is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label VXN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...